You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股收評:恒指跌1.27%,藥明系全天走低,半導體、蘋果概念股逆勢上揚

2月8日,港股三大指數延續跌勢,截至收盤,恒指跌1.27%,國指跌1.13%,恒生科技指數跌0.69%

盤面上,權重科技股多數下跌,阿里巴巴跌超6%,京東跌超2%,騰訊控股、快手跌超1%;美參院版《生物安全法》提案共同發起議員數恢復至6名,醫藥外包概念跌幅居前,藥明系悉數走低,藥明生物、藥明康德跌超7%;餐飲股下跌,百勝中國跌超5%;家電股、農產品股、煤炭股、啤酒股紛紛走低。

另一方面,半導體板塊逆勢走強,華虹半導體大升10%,上海復旦升超8%;內房股上升,金輝控股升超11%;消息稱蘋果將推出可摺疊iPhone,蘋果概念股表現活躍,高偉電子升超7%;軍工股、教育股、影視股、航空股等走高。

具體來看:

權重科技股多數下跌,阿里巴巴跌超6%,京東跌超2%,騰訊控股、快手跌超1%,小米、百度、美團微跌,網易微升。

醫藥外包概念跌幅居前,藥明系悉數走低,藥明生物、藥明康德跌超7%,凱萊英、昭衍新藥、金斯瑞生物科技等跟跌。

消息面上,今日美國國會官網顯示,由美國參議院議員加里·彼得斯在2023年12月20日提出的S.3558提案(即參院版《生物安全法》)的共同發起議員人數已恢復至原來的6名。

餐飲股下跌,百勝中國跌超5%,利寶閣集團、特海國際等跟跌。

半導體板塊繼續上升,華虹半導體升超10%,上海復旦、中芯國際、中電華大科技等跟升。

浦銀國際認為,半導體晶圓代工行業玩家會受益於庫存迴歸健康水位後的需求改善,尤其將受益於電子終端需求復甦以及AI需求強勁增長,今年基本面的週期上行動力強勁,半導體晶圓代工行業將重回增長。基於此維持對中國晶圓代工行業的樂觀判斷,中芯國際和華虹半導體都有望受益於今年行業週期上行動能。

教育股走高,卓越教育集團升超10%,思考樂教育、天立國際控股、新東方-S、中國東方教育、新高教集團等跟升。

民生證券表示,本週民辦教育協會發布編程類、舞蹈類校外培訓指引,非學科培訓政策不斷清晰,行業監管延續保護合規、打擊非法。從新東方、好未來等頭部企業財報來看,行業景氣度趨勢確定。

內房股上升,金輝控股升超11%,龍光集團、美的置業、融創中國、雅居樂集團、富力地產、新城發展等跟升。

平安證券指出,近期地產政策密集出台,除一線城市相繼優化限購外,全國首批城中村改造專項借款發放,房地產融資協調機制亦逐步推動落實。隨着政策利好因素持續發酵,疊加板塊及個股估值大幅回落,市場預期及機構持倉降至低點,當前板塊配置可適度積極。

蘋果概念股表現活躍,高偉電子升超7%,丘鈦科技、比亞迪電子、瑞聲科技等跟升。

消息稱蘋果正在研發至少兩款可橫向摺疊的翻蓋iPhone原型機。分析人士指出,隨着國產供應鏈趨於成熟,摺疊屏手機的售價有望進一步下降,這會刺激更多消費者嘗試這一手機形態,形成良性循環,與手機廠商合作緊密且產業鏈卡位良好的零部件供應商將受益。

個股方面:

阿里巴巴跌超6%,報70.3港元,成交額為79.8億港元。

消息面上,阿里巴巴2024財年Q3營收2603.5億元,同比增5%,低於預估的2612.5億元;經調整淨利潤479.51億元,同比下降4%。阿里巴巴將股票回購計劃規模擴大250億美元,回購總規模增至650億美元,回購有效期將延長至2027年3月底。

今日,南向資金淨買入45.91億港元,其中港股通(滬)淨買入29.9億港元,港股通(深)淨買入16.01億港元。

展望後市,中泰國際表示,海外貨幣政策轉松確定性不斷提升,國內降準落地打開寬貨幣空間,當前港股絕對及相對估值處於歷史極端水平,情緒與技術面接近底部,但春節短期反彈行情是否能轉化為持久升勢仍待經濟數據連續轉強驗證基本面復甦動力,以及針對性政策出台,後續仍需警惕港股盈利再下修風險的壓力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account